MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
IMGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

ImmunoGen (IMGN) Ownership - Who owns ImmunoGen?

Immunogen Inc is a clinical-stage biotechnology company from the United States... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
830 Winter Street
Phone
+1 781 895-0600
Employees
277
Web
https://www.immunogen.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.72B
P/E Ratio
N/A
Total Cash
605.54M
Projected Growth
N/A
Total Debt
84.33M
Revenue
287.61M
Risk (Beta)
0.57
Dividend Yield
N/A
Total Cash/Share
2.17
Total Debt/Equity
N/A
Revenue/Share
1.10 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for IMGN
A.I. Advisor
published General Information

General Information

a developer of anticancer therapeutics

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
830 Winter Street
Phone
+1 781 895-0600
Employees
277
Web
https://www.immunogen.com